Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (2682)	5/21/1998 11:02:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

This kind of profit-taking action and downward pressure on PFE is but a blip when viewed several months later. Nothing can disguise the fact that Viagra would be a wildly popular drug, and would bring billions of revenue to PFE. I watched a TV report today that in Taiwan they are selling Viagra in the black market for US $50 per pill, and the counterfeit pill (same kind of blue, same shape) is selling for the same price. Even Pfizer (Taiwan) couldn't differentiate between the two pills. It's a huge hit in Taiwan, and advertisements for their sale are in all the newspapers, though the drug is not yet approved there. I'm more concerned about the counterfeit pills; goodness knows what's in those pills (hopefully just placebos). Report said that Pfizer (Taiwan) is accelerating their action in applying for approval of Viagra in Taiwan.

To: BigKNY3 who wrote (2682)	5/22/1998 8:42:00 AM
From: BigKNY3	Respond to of 9523

Here are highlights from today's WSJ article: - Viagra, the blockbuster impotence medication from Pfizer Inc., has reached a milestone: one million new prescriptions sold since the drug became widely available six weeks ago. -The current rate puts Pfizer on track for $1 billion or more in annual sales, says Hemant Shah, a pharmaceutical analyst in Warren, N.J. -Despite that robust outlook, the average number of pills dispensed per prescription is down to less than 10 tablets from about 15 tablets during the first weeks of its release, Mr. Shah said. The decline in large part is due to the refusal of managed-care firms to pay for the drug for many patients, leaving them to buy the drug with their own money, Mr. Shah says. -Pfizer also has issued a statement reiterating guidelines on the appropriate use of the drug. The guidelines warn against the use of Viagra in combination with nitrates, such as nitroglycerin, commonly used for chest pain and note that the drug has not been approved for use by women, although clinical trials are under way. Pfizer also is issuing a letter for emergency room doctors and paramedics, specifically addressing the dangers of using Viagra in combination with nitrates, the spokeswoman said. BigKNY3